Hunter Schafer shares experience of gender-affirming bottom surgery in December

Hunter Schafer told Rolling Stone that she had gender‑affirming bottom surgery in December and described the experience as “amazing.” The 27‑year‑old actress, best known for her role on “Euphoria,” revealed the detail in an interview while promoting the upcoming “Blade Runner 2099” series, where she will play a lead character.

The disclosure comes at a moment when trans visibility in mainstream media is growing but still faces backlash. Schafer has been an outspoken advocate for trans rights since she began modeling and acting. Her decision to share the surgery follows a broader trend of public figures speaking openly about their medical transitions, a move that aims to normalize the procedures and combat stigma. Access to gender‑affirming care remains uneven in the United States, with many states imposing restrictions that limit insurance coverage and provider availability.

Fans and activists responded quickly to Schafer’s announcement. Social media users praised her honesty and called the surgery a personal triumph. Trans health organizations highlighted the story as evidence that successful surgeries can improve mental health and quality of life. Critics, however, seized on the moment to push anti‑trans narratives, underscoring the ongoing cultural fight over transgender rights. Schafer’s team did not release details about the type of procedure, respecting her privacy while confirming that she is recovering well.

Looking ahead, Schafer said she plans to use her platform to advocate for broader access to gender‑affirming care. She hinted that future interviews will focus on the medical journey and the policy changes needed to make such surgeries more affordable. Her role in “Blade Runner 2099” will bring her visibility to a global audience, potentially shifting public perception of trans bodies in science‑fiction storytelling. The conversation sparked by her revelation may influence both entertainment industry practices and legislative debates on trans health.